Companies: 10,795·Total market cap: $144.5T
Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.

CLDXNASDAQHealthcare● Active
$28.68
+$0.06(+0.22%)
Market Cap$1.9B
P/E Ratio
52W High$35.79
52W Low$19.25

Celldex Therapeutics, Inc.(CLDX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CLDX · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$1.50M$7.02M$6.88M$2.36M$4.65M
Cost of Revenue$0.00M$163.55M$118.01M$82.26M$53.31M
Gross Profit$1.50M($156.53M)($111.13M)($79.90M)($48.66M)
Gross Margin %(computed)100.00%
Operating Expenses
R&D Expenses$245.10M$163.55M$118.01M$82.26M$56.81M
G&A Expenses$43.80M$38.55M$30.91M$27.20M$20.49M
Total Operating Expenses$288.90M$38.55M$43.41M$35.33M$22.58M
Operating Income($287.40M)($195.08M)($154.54M)($115.23M)($71.24M)
Operating Margin %(computed)
Interest Income$28.61M$37.22M$13.11M$2.91M$0.51M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($258.80M)($157.86M)($141.43M)($112.33M)($70.74M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M($0.23M)
Net Income($258.80M)($157.86M)($141.43M)($112.33M)($70.51M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-3.90$-2.45$-2.92$-2.40$-1.64
Wtd Avg Shares66.50M64.39M48.45M46.89M42.87M
EBITDA($255.42M)($191.90M)($139.03M)($104.20M)($66.08M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Celldex Therapeutics, Inc.

关于Celldex Therapeutics, Inc.(CLDX)损益表

Celldex Therapeutics, Inc.(CLDX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CLDX实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.26B)(净利率-17253.33%)。

常见问题

CLDX · 4 问

Celldex Therapeutics, Inc.(CLDX)2025财年营收为$0.00B,同比down78.6%。

CLDX revenueCLDX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08